The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
The East Bengal have finally ended one of the Indian Football's lonest title after they…
NASCAR legend Kyle Busch passed away at the age of the 41. He was one…
India's ambitious restoration mission Project Cheetah is showing the strong momentum as the India's cheetah…
Delhi Forest Department set to develop the 'Vaman Van' which is an interactive biodiversity zone…
India has postponed the Fourth India-Africa Forum Summit which was schedule to be held in…
India and South Korea have strengthened the strategic relationship as Defense Minister of India Rajnath…